Breast Journal最新文献

筛选
英文 中文
Management of Idiopathic Granulomatous Mastitis: Effectiveness of a Steroid-Free Regimen Using Tinospora cordifolia-A Single-Institution Experience.
IF 1.9 4区 医学
Breast Journal Pub Date : 2025-01-22 eCollection Date: 2025-01-01 DOI: 10.1155/tbj/2997891
Ankita Das Sheth, Shalaka Joshi, Arul Kumar, Nita Nair, Tanuja Shet, Ayushi Sahay, Palak Thakkar, Purvi Haria, Aparna Katdare, Vani Parmar, Sangeeta Desai, Rajendra Badwe
{"title":"Management of Idiopathic Granulomatous Mastitis: Effectiveness of a Steroid-Free Regimen Using <i>Tinospora cordifolia</i>-A Single-Institution Experience.","authors":"Ankita Das Sheth, Shalaka Joshi, Arul Kumar, Nita Nair, Tanuja Shet, Ayushi Sahay, Palak Thakkar, Purvi Haria, Aparna Katdare, Vani Parmar, Sangeeta Desai, Rajendra Badwe","doi":"10.1155/tbj/2997891","DOIUrl":"10.1155/tbj/2997891","url":null,"abstract":"<p><p><b>Introduction:</b> Idiopathic granulomatous mastitis (IGM) is a benign, chronic inflammatory disease with no effective treatment and high relapse rate. The pathophysiology is poorly understood. Tinosporin, an immunomodulator obtained from <i>Tinospora cordifolia</i>, is known to be useful in treating immune-mediated diseases. We report our experience of using Tinosporin for IGM and the effectiveness of this \"steroid-free\" regimen. <b>Methods:</b> We analysed the clinicopathological characteristics of patients diagnosed with IGM on histopathology during January 2018 and December 2022. Tinosporin tablet (500 mg Guduchi stem extract) was prescribed for 3-6 months; data were collected from electronic medical records and analysed in SPSS v-29. <b>Results:</b> Of 315 patients, 132 had complete clinical records. Median age was 39 years (25-77), and 107 (81.7%) were premenopausal. Seventy-eight (59.09%) had clinical suspicion of malignancy. On imaging, 84 (63.64%) were BIRADS 4/5 lesions. Empirical broad-spectrum antibiotics were prescribed to 101 patients. Tinosporin tablets were prescribed to 91 patients. Symptomatic response was seen in 72 (79.12%). Five patients did not achieve response, while 14 patients (15.38%) were lost to follow-up. At a median follow-up of 36 months (14-62 months), only 2 patients on Tinosporin had recurrence. None of the patients needed surgical intervention other than diagnostic biopsy or control of infection, and none received steroids. <b>Conclusion:</b> IGM is a benign, often self-limiting disorder. However, it mimics malignancy in 60% cases, and histology clinches the diagnosis. We report the efficacy of steroid-free management of IGM with immunomodulatory herbal origin phytopharmaceutical drug Tinosporin. It is safe, inexpensive and effective. Large volume excisions or mastectomies can be reserved for severe and refractory cases.</p>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2025 ","pages":"2997891"},"PeriodicalIF":1.9,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11779988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143069841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intralesional Steroid Injections for Management of Granulomatous Mastitis: A Systematic Review of Treatment Protocols and Clinical Outcomes.
IF 1.9 4区 医学
Breast Journal Pub Date : 2025-01-21 eCollection Date: 2025-01-01 DOI: 10.1155/tbj/2592366
J Vercoe, N Sedaghat, M E Brennan
{"title":"Intralesional Steroid Injections for Management of Granulomatous Mastitis: A Systematic Review of Treatment Protocols and Clinical Outcomes.","authors":"J Vercoe, N Sedaghat, M E Brennan","doi":"10.1155/tbj/2592366","DOIUrl":"10.1155/tbj/2592366","url":null,"abstract":"<p><p><b>Introduction:</b> Although idiopathic granulomatous mastitis (GM) of the breast is a benign condition, it can be locally aggressive and frequently chronic, causing significant pain and distress to the patient. Treatment often involves multiple disciplines including general practice, breast surgery/physicians, rheumatology and/or immunology. Traditional options for treatment include observation, oral steroids, methotrexate and/or surgery, all with variable outcomes. A more recent alternative treatment option involves intralesional steroid injections. <b>Methods:</b> Using PRISMA methodology, a systematic review of intralesional steroid injection for the management of GM was conducted. Medline, PubMed, Embase and Cochrane databases were searched for original studies reporting treatment protocols and clinical outcomes, published up to the end of September 2023. <b>Results:</b> Nine eligible studies reported outcomes in 474 patients undergoing treatment of GM with intralesional injections. All studies reported success (improvement in clinical and/or imaging appearance) with intralesional injections. Studies that had a comparison group showed statistically significantly fewer side effects compared to oral steroids or surgical management. The recurrence rate was less for intralesional injections than for other treatments in all studies except one. No studies included patient-reported outcomes. <b>Conclusion:</b> There is consistent evidence for the safety, efficacy and low recurrence rate with intralesional steroid injections for GM. The existing literature is heterogenous with respect to injection protocols, and the optimal protocol is unclear. Future research should compare the various steroid agents and dose/frequency of administration. Future studies should include cost analysis and patient-reported outcomes to ensure that the treatment is cost-effective and acceptable to people with idiopathic GM.</p>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2025 ","pages":"2592366"},"PeriodicalIF":1.9,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143061591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker.
IF 1.9 4区 医学
Breast Journal Pub Date : 2025-01-10 eCollection Date: 2025-01-01 DOI: 10.1155/tbj/7861864
Yuli Wang, Jing Wang
{"title":"The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker.","authors":"Yuli Wang, Jing Wang","doi":"10.1155/tbj/7861864","DOIUrl":"10.1155/tbj/7861864","url":null,"abstract":"<p><p><b>Purpose:</b> Collagen type XI alpha 1 (COL11A1), a critical member of the collagen superfamily, is essential for tissue structure and integrity. This study aimed to validate previously identified variations in COL11A1 expression during breast cancer carcinogenesis and progression, as well as elucidate their clinical implications. <b>Methods:</b> COL11A1 mRNA expression levels were assessed using real-time reverse transcription-PCR (RT-PCR) in 30 pairs of normal breast tissue and primary breast cancer, 30 pairs of primary breast cancer and lymph node metastases, 30 benign tumors, and 107 primary breast cancers. COL11A1 protein expression was evaluated by Western blot in six matched trios of normal tissue, primary cancer, and lymph node metastasis. <b>Results:</b> COL11A1 mRNA levels were significantly higher in primary breast cancer tissues (<i>n</i> = 30) than in adjacent normal breast tissues (<i>p</i> < 0.001). Conversely, lymph node metastases (<i>n</i> = 30) showed significantly lower COL11A1 mRNA levels compared to their primary breast cancer counterparts (<i>p</i>=0.005). In a larger cohort, primary breast cancers (<i>n</i> = 107) had significantly elevated COL11A1 mRNA levels relative to adjacent normal tissues (<i>n</i> = 30) and benign tumors (<i>n</i> = 30) (<i>p</i> < 0.001). Benign tumors also demonstrated higher levels compared to normal tissues (<i>p</i>=0.012). The protein expression patterns were consistent with the mRNA findings. Receiver operating characteristic (ROC) curve analysis confirmed the diagnostic relevance of COL11A1 expression levels. Significant associations were found between COL11A1 mRNA levels and clinical parameters including lymph node involvement (<i>p</i>=0.046), clinical stage (<i>p</i>=0.004), and progesterone receptor status (<i>p</i>=0.048). Overexpression of COL11A1 was correlated with poor prognosis. <b>Conclusions:</b> COL11A1 expression varies during breast tumor initiation and progression, with elevated levels linked to worse prognoses. These findings underscore COL11A1's potential as a biomarker in breast cancer, suggesting its assessment could enhance diagnostic and prognostic strategies for more personalized patient management.</p>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2025 ","pages":"7861864"},"PeriodicalIF":1.9,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11752105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating YouTube Videos With Prophylactic Mastectomy Content in Terms of Their Quality and Reliability. 评估YouTube视频与预防性乳房切除术内容的质量和可靠性。
IF 1.9 4区 医学
Breast Journal Pub Date : 2025-01-09 eCollection Date: 2025-01-01 DOI: 10.1155/tbj/9487931
Tansu Altintas, Mehlika Bilgi Kirmaci
{"title":"Evaluating YouTube Videos With Prophylactic Mastectomy Content in Terms of Their Quality and Reliability.","authors":"Tansu Altintas, Mehlika Bilgi Kirmaci","doi":"10.1155/tbj/9487931","DOIUrl":"10.1155/tbj/9487931","url":null,"abstract":"<p><p><b>Aim:</b> Purpose of this study is to investigate the quality and reliability of YouTube video contents on prophylactic mastectomy. <b>Material and Methods:</b> The search terms \"prophylactic mastectomy,\" \"prophylactic mastectomy surgery,\" \"preventive surgery for breast cancer,\" \"risk-reducing mastectomy,\" and \"prophylactic mastectomy and breast reconstruction\" were searched on YouTube. The uploader, video content, length (seconds), upload date, number of days since upload date, number of views, number of comments, and likes were recorded and evaluated. Finally, the videos included in the study were evaluated using modified Quality Criteria for Consumer Health Information (DISCERN) and Global Quality Scale (GQS). <b>Results:</b> The total number of views of the 50 videos reviewed in the study was found as 3.674.469. The mean DISCERN score of the two observers was calculated as 3.35 ± 1, and the videos were found to be of medium reliability. The mean GQS score of all videos was 3.39 ± 0.9 and the videos were of medium quality. The researchers gave 1-2 points (misleading) to 7 (14%) videos, 3 points (somewhat helpful) to 20 (40%) videos, 4 points (beneficial) to 16 (32%) videos, and 5 points (excellent) to 7 (14%) videos. <b>Conclusion:</b> In our study, we found that the videos uploaded by doctors were of good quality, the videos uploaded by health channels were of medium quality, and the videos uploaded by patients were of poor quality and misleading. The videos with health contents should be evaluated by the relevant specialists, and only useful videos should be broadcast.</p>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2025 ","pages":"9487931"},"PeriodicalIF":1.9,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737905/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Radiologic Analysis of 2964 Papillary Breast Lesions. 乳腺乳头状病变2964例临床放射学分析。
IF 1.9 4区 医学
Breast Journal Pub Date : 2024-12-24 eCollection Date: 2024-01-01 DOI: 10.1155/tbj/5639017
Hanyu Zhang, Anbang Hu, Yanling Li, Mingcui Li, Zhiyuan Rong, Weilun Cheng, Yansong Liu, Yunqiang Duan, Jianyuan Feng, Ziang Chen, Tianshui Yu, Jiarui Zhang, Ting Wang, Yuhang Shang, Zhengbo Fang, Jiangwei Liu, Fanjing Kong, Fei Ma, Baoliang Guo
{"title":"Clinical Radiologic Analysis of 2964 Papillary Breast Lesions.","authors":"Hanyu Zhang, Anbang Hu, Yanling Li, Mingcui Li, Zhiyuan Rong, Weilun Cheng, Yansong Liu, Yunqiang Duan, Jianyuan Feng, Ziang Chen, Tianshui Yu, Jiarui Zhang, Ting Wang, Yuhang Shang, Zhengbo Fang, Jiangwei Liu, Fanjing Kong, Fei Ma, Baoliang Guo","doi":"10.1155/tbj/5639017","DOIUrl":"10.1155/tbj/5639017","url":null,"abstract":"<p><p><b>Background:</b> Clinical management of papillary breast lesions (PBLs) remains controversial. Our objective was to analyze the independent risk factors associated with malignant PBLs. <b>Methods:</b> A retrospective review of clinical variables in 2964 patients with papillary lesions available for evaluation. <b>Results:</b> This retrospective study screened that older patients (≥ 50 years), postmenopausal, palpable tumor, tumor size ≥ 15 mm, peripheral tumor, and tumor with calcification were independent risk factors affecting malignant PBLs. Moreover, the probability of malignant PBLs without the appealed risk factors was only 3.4%. <b>Conclusions:</b> Patients without risk factors for papillary lesions can manage their health with imaging surveillance. The choice of surgical treatment for the remaining patients is a reasonable recommendation.</p>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2024 ","pages":"5639017"},"PeriodicalIF":1.9,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142916051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catheter Tip Migration in Female Patients With Breast Cancer: A Retrospective Comparative Study of Right- and Left-Sided Chest Ports 女性乳腺癌患者导管尖端移位:左、右侧胸口的回顾性比较研究
IF 1.9 4区 医学
Breast Journal Pub Date : 2024-12-20 DOI: 10.1155/tbj/7358397
Alexander T. O’Mahony, Aidan Coffey, Patrick W. O’Regan, Emily Walsh, Brian Carey, James Ryan, Niamh Dorney, Owen J. O’Connor, Jack Gleeson, Stephen P. Power
{"title":"Catheter Tip Migration in Female Patients With Breast Cancer: A Retrospective Comparative Study of Right- and Left-Sided Chest Ports","authors":"Alexander T. O’Mahony,&nbsp;Aidan Coffey,&nbsp;Patrick W. O’Regan,&nbsp;Emily Walsh,&nbsp;Brian Carey,&nbsp;James Ryan,&nbsp;Niamh Dorney,&nbsp;Owen J. O’Connor,&nbsp;Jack Gleeson,&nbsp;Stephen P. Power","doi":"10.1155/tbj/7358397","DOIUrl":"https://doi.org/10.1155/tbj/7358397","url":null,"abstract":"<div>\u0000 <p><b>Introduction:</b> Chest ports are typically inserted via the right internal jugular vein with the left side being utilized in certain patient populations. The purpose of this study was to evaluate the dynamic position of the chest port and catheter tip, comparing a demographically matched cohort of female breast cancer patients with right- or left-sided chest ports.</p>\u0000 <p><b>Methods:</b> 142 female patients with breast cancer requiring chest port insertion for chemotherapy and imaging confirming catheter tip position initially with supine fluoroscopy and follow-up with erect chest radiography over a 5-year period were identified. Data points analyzed were catheter tip-to-carina distance and the distance from the port to the ipsilateral infraclavicular border. Intraprocedural measurements were taken in the supine position during chest port insertion and compared with follow-up erect chest radiography. The catheter tip position was also allocated a zone within the venous system on both image sets to assess for significant retraction to a more proximal zone in the erect position. Imaging within 12-months of chest port insertion was also screened to identify port-related complications.</p>\u0000 <p><b>Results:</b> The whole cohort showed significant retraction of the catheter tip (cephalad) (<i>p</i> &lt; 0.001) and protraction of the port (caudal) (<i>p</i> &lt; 0.001). The median tip-to-carina distance decreased from 38.3 mm to 28.6 mm and the port-to-clavicle distance increased from 31.3 mm to 64.6 mm. Right-sided chest ports had increased tip-to-catheter retraction (15 mm) compared with left-sided (6.9 mm) (<i>p</i> = 0.310). A complication was identified in 8.5% of the right-sided and 11% of the left-sided ports. Zone migration was significantly associated with the occurrence of a complication in left-sided ports (<i>p</i> = 0.023).</p>\u0000 <p><b>Conclusion:</b> When assessing chest port catheter tip position between supine and erect radiographic studies in female patients with breast cancer, retraction cephalad will occur and this is more apparent in right-sided ports. Change in catheter tip position was not associated with a significant increase in complication rate unless it occurred in left-sided ports where zone migration was evident.</p>\u0000 </div>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2024 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbj/7358397","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142862060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Breast Malignancy in Children and Adolescents: A Population-Based Study 儿童和青少年原发性乳腺恶性肿瘤:一项基于人群的研究
IF 1.9 4区 医学
Breast Journal Pub Date : 2024-12-05 DOI: 10.1155/tbj/2919922
Guorong He, Nan Shen, Lingling Zhao, Xian Liu, Caiyun Zhang
{"title":"Primary Breast Malignancy in Children and Adolescents: A Population-Based Study","authors":"Guorong He,&nbsp;Nan Shen,&nbsp;Lingling Zhao,&nbsp;Xian Liu,&nbsp;Caiyun Zhang","doi":"10.1155/tbj/2919922","DOIUrl":"https://doi.org/10.1155/tbj/2919922","url":null,"abstract":"<div>\u0000 <p><b>Purpose:</b> Primary breast cancer in children and adolescents is extremely uncommon and presents with different characteristics from those found in adult women. We aimed to conduct a population-based cohort study to predict overall survival (OS) in pediatric patients with breast cancer.</p>\u0000 <p><b>Methods:</b> Demographic and clinicopathological data on pediatric breast cancer patients were obtained from the Surveillance, Epidemiology, and End Results database (2000–2019). The survival rates were measured using the Kaplan–Meier method. Univariate survival analysis used the log-rank test, while multivariate analysis used Cox proportional hazards regression to identify factors influencing OS. Furthermore, we created a nomogram to predict OS in pediatric patients.</p>\u0000 <p><b>Results:</b> A total of 115 pediatric patients were analyzed, with a median age at diagnosis of 18 years (range: 2–19 years). In terms of tumor grade, 27 (23.4%) patients had well or moderately differentiated tumors and 32 (27.8%) had poorly or undifferentiated tumors. The predominant histological type was phyllodes tumor, accounting for 36.5%, followed by infiltrating duct carcinoma at 31.3%, and other types at 32.2%. The SEER and M stages were substantial independent indicators of OS. A nomogram was created to predict OS in pediatric breast cancer patients.</p>\u0000 <p><b>Conclusions:</b> Our findings confirmed that the SEER stage and M stage were the most critical predictors of OS in pediatric patients with breast cancer. By focusing on this rare demographic, our study fills an important gap in the literature, as there are few comprehensive studies available that explore a prognosis in pediatric breast cancer.</p>\u0000 </div>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2024 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbj/2919922","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142859987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Port Three-Dimensional Endoscopic-Assisted Axillary Lymph Node Dissection (S-P 3D E-ALND): Surgical Technique and Preliminary Results 单孔三维内镜辅助腋窝淋巴结清扫术(S-P 3D E-ALND):手术技术和初步结果
IF 1.9 4区 医学
Breast Journal Pub Date : 2024-12-04 DOI: 10.1155/tbj/6319218
Chayanee Sae-Lim, Hung-Wen Lai, Papawee Chennavasin, Hsin-I Huang, Shih-Lung Lin, Ren-Hung Huang, Shou-Tung Chen, Dar-Ren Chen
{"title":"Single-Port Three-Dimensional Endoscopic-Assisted Axillary Lymph Node Dissection (S-P 3D E-ALND): Surgical Technique and Preliminary Results","authors":"Chayanee Sae-Lim,&nbsp;Hung-Wen Lai,&nbsp;Papawee Chennavasin,&nbsp;Hsin-I Huang,&nbsp;Shih-Lung Lin,&nbsp;Ren-Hung Huang,&nbsp;Shou-Tung Chen,&nbsp;Dar-Ren Chen","doi":"10.1155/tbj/6319218","DOIUrl":"https://doi.org/10.1155/tbj/6319218","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Endoscopic-assisted breast surgery (EABS) provides better cosmetic outcomes for breast cancer patients with small incisions in an inconspicuous area. However, an extended incision and heavy assistant retraction are usually required for an adequate exposure for conventional axillary lymph node dissection (ALND). Therefore, we propose an innovative single-port three-dimensional endoscopic-assisted ALND (S-P 3D E-ALND) to facilitate better visualization, and report its preliminary outcomes herein.</p>\u0000 <p><b>Methods:</b> The surgical technique of the S-P 3D E-ALND, using either monopolar Endo Hook, LigaSure, or <i>Sonicision</i>, is described. A total of 11 breast cancer patients who received the S-P 3D E-ALND in a single institution from January 2023 to September 2023 were enrolled. The preliminary results of the S-P 3D E-ALND, including perioperative parameters, complication, and short-term oncological outcomes, were retrospectively analyzed.</p>\u0000 <p><b>Results:</b> Endoscopic breast and axillary procedures were conducted via a single axillary incision. The primary success rate of the S-P 3D E-ALND was 100% without a conversion to open surgery. The median operative time for the S-P 3D E-ALND was 39 (IQR = 28, 49) minutes. Average blood loss during E-ALND was 3 (IQR = 3, 5) mL. The median number of harvested LN was 10 (IQR = 8, 11) LNs. During the median follow-up time of 7 months, there was no complication, lymphedema, shoulder stiffness, or chronic arm numbness found. None of the patients reported locoregional recurrence, distant metastasis, or mortality.</p>\u0000 <p><b>Conclusion:</b> The S-P 3D E-ALND can serve as an alternative approach for ALND in breast cancer patients undergoing EABS, as our findings indicate it results in only minor complications.</p>\u0000 </div>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2024 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbj/6319218","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142764094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intramammary Tumor Location and Ipsilateral Lymphatic Spread in Early Breast Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) Assay 使用一步核酸扩增(OSNA)测定早期乳腺癌患者的乳腺内肿瘤位置和同侧淋巴扩散情况
IF 1.9 4区 医学
Breast Journal Pub Date : 2024-11-08 DOI: 10.1155/2024/4864443
Mariana Robalo Cordeiro, Inês Gante, Daniela David, Ana Gomes, Margarida Figueiredo-Dias
{"title":"Intramammary Tumor Location and Ipsilateral Lymphatic Spread in Early Breast Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) Assay","authors":"Mariana Robalo Cordeiro,&nbsp;Inês Gante,&nbsp;Daniela David,&nbsp;Ana Gomes,&nbsp;Margarida Figueiredo-Dias","doi":"10.1155/2024/4864443","DOIUrl":"https://doi.org/10.1155/2024/4864443","url":null,"abstract":"<div>\u0000 <p>Establishing an accurate prognosis for women diagnosed with breast cancer (BC) is extremely challenging. Axillary lymph node (ALN) evaluation is considered of major prognostic value. The one-step nucleic acid amplification (OSNA) assay is currently used for assessing axillary sentinel lymph node (SLN) status in BC. Additionally, total tumor load (TTL) may help predict further metastatic axillary involvement beyond the SLN. The prognostic value of primary BC location remains controversial due to lack of consensus on the biological differences among tumors at various sites. Evidence suggests that tumors in the internal quadrants (INLs) have worse prognosis compared to those in the external quadrants. Furthermore, ALN involvement is believed to be mainly associated with external quadrant tumors, mainly due to the lymphatic drainage system of the breast. This pilot observational study, despite lacking a control group and having a relatively small sample size, is the first to evaluate the potential relationship between primary BC location and ALN metastasis using the OSNA assay. A sample of consecutive BC patients undergoing axillary staging with the OSNA assay were included. Tumors were categorized into three groups based on primary location: external quadrants and axillary tail (EXL), INLs, and nipple and areola location (NAL). Although not statistically significant, the INL group exhibited a higher mean TTL. Additionally, no significant differences were observed between groups concerning SLN detection techniques, SLN status, number of metastatic SLN, or mean TTL. These findings support the use of the innovative tracer superparamagnetic iron oxide regardless of tumor site. This study underscores the importance of understanding the relationship between BC location and ALN status, which may improve prognostic stratification and targeted therapies based on tumor site. If these observations are confirmed in larger, multicentric studies, the potential conclusions may shift the paradigm of INL tumor treatment, significantly impacting clinical practice and research.</p>\u0000 </div>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2024 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/4864443","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142664522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between Mitochondrial Biological Function and Breast Cancer 线粒体生物功能与乳腺癌的关系
IF 1.9 4区 医学
Breast Journal Pub Date : 2024-11-06 DOI: 10.1155/2024/4434466
Shichen Miao, Qichao Ni, Jun Fang
{"title":"Relationship Between Mitochondrial Biological Function and Breast Cancer","authors":"Shichen Miao,&nbsp;Qichao Ni,&nbsp;Jun Fang","doi":"10.1155/2024/4434466","DOIUrl":"https://doi.org/10.1155/2024/4434466","url":null,"abstract":"<div>\u0000 <p><b>Objective:</b> This study aims to investigate the potential causal link between mitochondrial function and breast cancer using the Mendelian randomization (MR) analysis.</p>\u0000 <p><b>Methods:</b> The data used for this study were obtained from genomewide association studies (GWAS) databases on mitochondrial biological function and breast cancer. Mitochondrial function was considered the exposure variable, breast cancer the outcome variable, and specific single nucleotide polymorphisms (SNPs) were selected as instrumental variables (IVs). Two MR methods, inverse variance weighting (IVW) and MR-Egger regression, were used to assess the causal association between mitochondrial function and breast cancer. Data analysis and visualization were performed using R software.</p>\u0000 <p><b>Results:</b> The results of the analysis revealed that several genes, including 39S ribosomal protein L34, pyruvate carboxylase, rRNA methyltransferase 3, and cytochrome c oxidase assembly factor 3 homolog, are causally linked to an increased risk of breast cancer in European populations. In addition, cytochrome c oxidase subunit 8A and ADP-ribose pyrophosphatase were found to be protective factors against breast cancer in European populations. In East Asian populations, 39S ribosomal protein L52, ATP synthase subunit beta, and pyruvate dehydrogenase (acetyl-transferring) were identified as causal risk factors for breast cancer. Conversely, 39S ribosomal protein L32, ADP-ribose pyrophosphatase, and cytochrome c oxidase subunit 8A were identified as protective factors against breast cancer in this population.</p>\u0000 <p><b>Conclusion:</b> In conclusion, this study provides evidence of a causal relationship between mitochondrial function and breast cancer in both European and East Asian populations. Additional research is warranted to further elucidate the mechanisms underlying this association.</p>\u0000 </div>","PeriodicalId":56326,"journal":{"name":"Breast Journal","volume":"2024 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/4434466","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142596299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信